$KALV
KalVista Pharmaceuticals, Inc.

2018 Q1 Form 10-Q Financial Statement

#000156459018006049 Filed on March 16, 2018

View on sec.gov

Income Statement

Concept 2018 Q1 2017 Q2 2017 Q1
Revenue $2.331M $114.0K $248.0K
YoY Change 839.92% -63.69% -28.74%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.130M $2.200M $5.030M
YoY Change -57.65% -15.38% 226.62%
% of Gross Profit
Research & Development $4.548M $3.000M $3.339M
YoY Change 36.21% 216.79% -7.81%
% of Gross Profit
Depreciation & Amortization $50.00K $10.00K $0.00
YoY Change -100.0%
% of Gross Profit
Operating Expenses $6.677M $5.200M $8.365M
YoY Change -20.18% -3.7% 100.94%
Operating Profit -$8.117M
YoY Change 112.77%
Interest Expense -$1.870M -$140.0K -$190.0K
YoY Change 884.21% -64.1% -315.91%
% of Operating Profit
Other Income/Expense, Net -$888.0K $1.020M $473.0K
YoY Change -287.74% -74.61%
Pretax Income -$5.230M -$4.200M -$7.640M
YoY Change -31.54% -42.86% 15.58%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$5.234M -$4.202M -$7.644M
YoY Change -31.53% -13.7% 291.6%
Net Earnings / Revenue -224.54% -3685.96% -3082.26%
Basic Earnings Per Share
Diluted Earnings Per Share -$484.7K -$439.8K -$997.4K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2018 Q1 2017 Q2 2017 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $58.70M $31.00M $33.50M
YoY Change 75.22% -15.76% -30.93%
Cash & Equivalents $58.68M $30.95M $33.50M
Short-Term Investments
Other Short-Term Assets $2.000M $800.0K $1.200M
YoY Change 66.67% -27.27% 20.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $65.70M $34.20M $38.00M
YoY Change 72.89% 38.62% -23.23%
LONG-TERM ASSETS
Property, Plant & Equipment $800.0K $97.00K $100.0K
YoY Change 700.0% 31.08% -50.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $200.0K $50.00K
YoY Change -50.0%
Total Long-Term Assets $1.000M $147.0K $100.0K
YoY Change 900.0% -98.9% -42.86%
TOTAL ASSETS
Total Short-Term Assets $65.70M $34.20M $38.00M
Total Long-Term Assets $1.000M $147.0K $100.0K
Total Assets $66.70M $34.35M $38.10M
YoY Change 75.07% -9.64% -23.3%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.600M $1.153M $800.0K
YoY Change 100.0% 516.58% 0.88%
Accrued Expenses $2.300M $1.865M $2.400M
YoY Change -4.17% 8.87% 121.81%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $200.0K
YoY Change
Total Short-Term Liabilities $24.10M $3.018M $3.200M
YoY Change 653.13% 56.45% -16.97%
LONG-TERM LIABILITIES
Long-Term Debt $100.0K $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $13.90M
YoY Change
Total Long-Term Liabilities $14.01M $0.00 $0.00
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $24.10M $3.018M $3.200M
Total Long-Term Liabilities $14.01M $0.00 $0.00
Total Liabilities $38.10M $3.000M $3.200M
YoY Change 1090.63% 52.21% -51.54%
SHAREHOLDERS EQUITY
Retained Earnings -$71.00M -$55.86M -$51.65M
YoY Change 37.46% -35.49% -34.8%
Common Stock $99.71M $89.83M $89.40M
YoY Change 11.53% -26.74% -26.9%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $28.57M $31.33M $34.85M
YoY Change
Total Liabilities & Shareholders Equity $66.70M $34.35M $38.05M
YoY Change 75.3% -9.64% -23.4%

Cashflow Statement

Concept 2018 Q1 2017 Q2 2017 Q1
OPERATING ACTIVITIES
Net Income -$5.234M -$4.202M -$7.644M
YoY Change -31.53% -13.7% 291.6%
Depreciation, Depletion And Amortization $50.00K $10.00K $0.00
YoY Change -100.0%
Cash From Operating Activities $28.22M -$2.640M -$7.120M
YoY Change -496.35% -63.64% 40.16%
INVESTING ACTIVITIES
Capital Expenditures -$180.0K $0.00 $180.0K
YoY Change -200.0% -100.0% -2.17%
Acquisitions
YoY Change
Other Investing Activities $0.00 $33.96M
YoY Change -100.0%
Cash From Investing Activities -$180.0K $0.00 $34.13M
YoY Change -100.53% -100.0% -19061.11%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -50.00K 0.000 4.490M
YoY Change -101.11% -100.0%
NET CHANGE
Cash From Operating Activities 28.22M -2.640M -7.120M
Cash From Investing Activities -180.0K 0.000 34.13M
Cash From Financing Activities -50.00K 0.000 4.490M
Net Change In Cash 27.99M -2.640M 31.50M
YoY Change -11.14% -77.32% -698.86%
FREE CASH FLOW
Cash From Operating Activities $28.22M -$2.640M -$7.120M
Capital Expenditures -$180.0K $0.00 $180.0K
Free Cash Flow $28.40M -$2.640M -$7.300M
YoY Change -489.04% -63.28% 38.68%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
2507000
CY2017Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2643000
CY2017Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
97000
CY2018Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
2434000
us-gaap Net Income Loss
NetIncomeLoss
-15148000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-5.50
us-gaap Net Income Loss
NetIncomeLoss
-14401000
CY2017Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
166000
CY2018Q1 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
117000
CY2018Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
14006000
CY2018Q1 us-gaap Common Stock Value
CommonStockValue
11000
CY2018Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
99696000
CY2018Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-71003000
CY2018Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-136000
CY2018Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2017Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2017Q2 us-gaap Assets
Assets
34345000
CY2017Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1153000
CY2017Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1865000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2852000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
3013073
CY2018Q1 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
222000
CY2018Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4548000
CY2017Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3339000
CY2018Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10792646
CY2017Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10792646
CY2018Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2129000
CY2018Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10792646
CY2017Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10792646
CY2018Q1 us-gaap Revenues
Revenues
2331000
CY2017Q1 us-gaap Revenues
Revenues
248000
us-gaap Revenues
Revenues
3554000
us-gaap Operating Expenses
OperatingExpenses
18643000
us-gaap Operating Income Loss
OperatingIncomeLoss
-15736000
us-gaap Investment Income Interest
InvestmentIncomeInterest
17000
us-gaap Investment Income Interest
InvestmentIncomeInterest
31000
CY2018Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-1887000
CY2017Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-195000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-1836000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
1511000
CY2018Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
985000
CY2017Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
661000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2407000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1310000
CY2018Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-888000
CY2017Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
473000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
588000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-5234000
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
-7644000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2832000
CY2018Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2800000
CY2017Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7478000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-12641000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-17233000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
779000
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
500000
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
1464000
kalv Increase Decrease In Research And Development Tax Credit Receivable
IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable
2383000
kalv Increase Decrease In Research And Development Tax Credit Receivable
IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable
1303000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1206000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
689000
kalv Increase Decrease In Grants And Other Receivables
IncreaseDecreaseInGrantsAndOtherReceivables
-281000
kalv Increase Decrease In Grants And Other Receivables
IncreaseDecreaseInGrantsAndOtherReceivables
-36000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
123000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
548000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1957000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
332000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1560000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
33804000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
16513000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-21081000
us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
34139000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
343000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
67000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-343000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
34072000
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
101000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
9100000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
8999000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
2000
us-gaap Effect Of Exchange Rate On Cash
EffectOfExchangeRateOnCash
2559000
us-gaap Effect Of Exchange Rate On Cash
EffectOfExchangeRateOnCash
-1259000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
27728000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
11734000
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21764000
CY2017Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
33498000
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
513000
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
58608000
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
0
CY2018Q1 kalv Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-5234000
CY2017Q1 kalv Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-7855000
kalv Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-15148000
kalv Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-16573000
CY2018Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1051000
CY2017Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1300000
CY2018Q1 kalv Accrued Research Expense
AccruedResearchExpense
753000
CY2017Q2 kalv Accrued Research Expense
AccruedResearchExpense
348000
CY2018Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
233000
CY2017Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
146000
CY2018Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
253000
CY2017Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
71000
CY2018Q1 kalv Contractual Obligation Remaining Commitment Including Cancellation Provisions
ContractualObligationRemainingCommitmentIncludingCancellationProvisions
8800000
kalv Capital Lease Term
CapitalLeaseTerm
P24M
kalv Capital Lease Down Payment Made
CapitalLeaseDownPaymentMade
102000
CY2018Q1 kalv Capital Lease Future Monthly Payments To Be Paid Over Term Of Lease
CapitalLeaseFutureMonthlyPaymentsToBePaidOverTermOfLease
18000
CY2018Q1 us-gaap Capital Leases Future Minimum Payments Remainder Of Fiscal Year
CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear
59000
CY2018Q1 us-gaap Capital Leases Future Minimum Payments Due In Two Years
CapitalLeasesFutureMinimumPaymentsDueInTwoYears
234000
CY2018Q1 us-gaap Capital Leases Future Minimum Payments Due In Three Years
CapitalLeasesFutureMinimumPaymentsDueInThreeYears
59000
CY2018Q1 us-gaap Capital Leases Future Minimum Payments Due
CapitalLeasesFutureMinimumPaymentsDue
352000
CY2018Q1 us-gaap Capital Leases Future Minimum Payments Interest Included In Payments
CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments
13000
CY2018Q1 us-gaap Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments
CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments
339000
CY2018Q1 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
86000
CY2018Q1 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
223000
CY2018Q1 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
225000
CY2018Q1 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
228000
CY2018Q1 kalv Operating Leases Future Minimum Payments Due In Five Years And Thereafter
OperatingLeasesFutureMinimumPaymentsDueInFiveYearsAndThereafter
328000
CY2018Q1 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
1090000
CY2017Q4 kalv Number Of Units Of Accounting
NumberOfUnitsOfAccounting
3
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
kalv Tax Cuts And Jobs Act Of2017 Impact On Tax Provision
TaxCutsAndJobsActOf2017ImpactOnTaxProvision
0

Files In Submission

Name View Source Status
0001564590-18-006049-index-headers.html Edgar Link pending
0001564590-18-006049-index.html Edgar Link pending
0001564590-18-006049.txt Edgar Link pending
0001564590-18-006049-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
kalv-10q_20180131.htm Edgar Link pending
kalv-20180131.xml Edgar Link completed
kalv-20180131.xsd Edgar Link pending
kalv-20180131_cal.xml Edgar Link unprocessable
kalv-20180131_def.xml Edgar Link unprocessable
kalv-20180131_lab.xml Edgar Link unprocessable
kalv-20180131_pre.xml Edgar Link unprocessable
kalv-ex311_10.htm Edgar Link pending
kalv-ex312_6.htm Edgar Link pending
kalv-ex321_8.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending